DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains

MLA

Instituto de Salud Carlos III, et al. DNA Damage Response-Related Alterations Define the Genetic Background of Patients with Chronic Lymphocytic Leukemia and Chromosomal Gains. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1286538182&authtype=sso&custid=ns315887.

APA

Instituto de Salud Carlos III, European Commission, Red Temática de Investigación Cooperativa en Cáncer (España), Centro de Investigación Biomédica en Red Cáncer (España), Sociedad Española de Hematología y Hemoterapia, Junta de Castilla y León, Hernández-Sánchez, M., Rodríguez-Vicente, A. E., González-Gascón y Marín, I., Quijada-Álamo, M., Hernandez-Sánchez, J. M., Martín-Izquierdo, M., Hernández-Rivas, J. A., Benito, R., & Hernández, J. M. (2019). DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains.

Chicago

Instituto de Salud Carlos III, European Commission, Red Temática de Investigación Cooperativa en Cáncer (España), Centro de Investigación Biomédica en Red Cáncer (España), Sociedad Española de Hematología y Hemoterapia, Junta de Castilla y León, María Hernández-Sánchez, et al. 2019. “DNA Damage Response-Related Alterations Define the Genetic Background of Patients with Chronic Lymphocytic Leukemia and Chromosomal Gains.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1286538182&authtype=sso&custid=ns315887.